A model system for measuring comparative toxicities of cardiotoxic drugs with cultured rat heart myocytes, endothelial cells and fibroblasts. I. Emetine, chloroquine and metronidazole.
Neonatal rat hearts were separated into separate cultures of beating myocytes (M cells), endothelial cells (E cells) and fibroblasts (F cells). Their susceptibilities to the toxic effects of emetine, chloroquine and metronidazole were then compared using a quantitative metabolic inhibition test (QMIT) and morphologic and beating changes as indices of injury. Measurements on the same cultures were made at 6 h and 12 h daily for 7 days with E and F cells; with M cells for 3 days. Metronidazole was non-toxic for all cell types at 810 micrograms/ml, whether as the parent compound or after attempted rat liver microsomal activation. QMIT data, integrated as time-concentration effects, showed all cell responses to either emetine or chloroquine to be parallel (P less than 0.05), and their order of susceptibility to be: E greater than M greater than F cells. Although morphologic signs of injury and changes in beating are not readily evaluated statistically, there was a general parallelism between these indices of injury and those of QMIT. As judged by QMIT emetine was more toxic than chloroquine. However, at equivalent QMIT grades chloroquine produced greater effects on morphology and beating. Toxic concentration-50 values for chloroquine with the QMIT were similar to reported human toxic and lethal blood concentrations.
D000818:Animals; D002478:Cells, Cultured; D002738:Chloroquine / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004640:Emetine / Q000633:toxicity*; D004727:Endothelium / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D008795:Metronidazole / Q000633:toxicity*; D009206:Myocardium / Q000378:metabolism; D051381:Rats
D008795:Metronidazole; D002738:Chloroquine; D004640:Emetine